Abstract
Introduction School-age health, growth and development are poorly characterised in low- and middle-income countries. We developed the School-Age Health, Activity, Resilience, Anthropometry and Neurocognitive (SAHARAN) toolbox to measure growth, cognitive and physical function in rural Zimbabwe.
Methods The SAHARAN toolbox was developed using a stepwise approach, with tool selection based on COSMIN principles. Growth was measured with anthropometry, skinfold thicknesses and bioimpedance analysis to obtain lean mass index (LMI) and phase angle. Cognition was assessed using a fine motor finger tapping task, school achievement test (SAT), and the Kaufmann Assessment Battery for Children (KABC-2) to determine the mental processing index (MPI). Physical function combined grip strength, broad jump and the 20m shuttle run test to produce a total physical score (TPS). A detailed caregiver questionnaire was performed in parallel.
Results 80 Zimbabwean children with mean (SD) age 7.6 (0.2) years had mean height-for-age (HAZ) and weight-for-age Z-scores (WAZ) of −0.63 (0.81) and −0.55 (0.85), respectively. For growth measures, LMI and total skinfold thicknesses were highly related to both WAZ and BMI Z-score, but not to HAZ. For physical function, TPS was associated with unit rises in HAZ (1.29, 95%CI 0.75,1.82, p<0.001), and LMI (0.50, 95%CI 0.16,0.83, p=0.004), but not skinfold thicknesses. For cognition, the SAT was highly associated with unit increases in the MPI (0.9 marks, 95%CI 0.4,1.3, p<0.001) and a child socioemotional questionnaire (8.2 marks, 95%CI 2.9,13.5, p=0.003). Phase angle was associated with 3.5 seconds quicker time to complete the finger tapping task (95%CI 0.6,6.4, p=0.02). No child outcomes were associated with socioeconomic status, nurturing, discipline, food and water insecurity, or household adversity.
Conclusions We found clear associations between growth, height-adjusted lean mass and physical function, but not cognitive function, in a cohort of Zimbabwean children. The SAHARAN toolbox could be deployed to characterise school-age growth, development and function in sub-Saharan Africa.
What is already known?
There are a lack of available tools to measure school-age health, growth, physical function and cognitive function together, particularly in low-resource settings.
Early-life quality of growth is associated with future chronic disease risk.
What are the new findings?
School-age markers of growth and lean mass (but not fat mass) were strongly associated with physical function.
Cognitive function was related to schooling and to the child’s perceived socioemotional score.
What do the new findings imply?
The SAHARAN toolbox enables an integrated assessment of school-age health, growth, physical and cognitive function.
The quality of early-life growth and relative lean mass is important at school-age, since it is associated with better physical function and reduced chronic disease risk.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
MRCZ/A/1675
Funding Statement
Wellcome Trust provided funding for this work and the salary of JDP. Grant number: 220671/Z/20/Z "Effect of early-life nutrition and WASH interventions on the long-term health of Zimbabwean children". AJP is funded by Wellcome Trust grant number 108065/Z/15/Z. Additional funding is from National Institutes of Health (NIH) Grant number R61HD103101, and research grants from the Thrasher Research Fund and Innovative Methods and Metrics for Agriculture and Nutrition Actions (IMMANA).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was provided by the Medical Research Council of Zimbabwe. Caregivers gave written informed consent and children gave written assent to participate.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Supplementary material will be added.
